Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
8.53
-0.27 (-3.07%)
Feb 28, 2025, 2:45 PM CST
SHE:300009 Revenue
Anhui Anke Biotechnology (Group) had revenue of 622.47M CNY in the quarter ending September 30, 2024, a decrease of -15.21%. This brings the company's revenue in the last twelve months to 2.77B, up 4.53% year-over-year. In the year 2023, Anhui Anke Biotechnology (Group) had annual revenue of 2.87B with 22.94% growth.
Revenue (ttm)
2.77B
Revenue Growth
+4.53%
P/S Ratio
5.14
Revenue / Employee
926.20K
Employees
2,986
Market Cap
14.23B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.87B | 534.69M | 22.94% |
Jan 1, 2023 | 2.33B | 162.30M | 7.48% |
Dec 31, 2021 | 2.17B | 467.35M | 27.47% |
Dec 31, 2020 | 1.70B | -11.11M | -0.65% |
Dec 31, 2019 | 1.71B | 250.98M | 17.17% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
Jiangsu Hengrui Medicine | 26.00B |
WuXi AppTec | 38.50B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Shanghai United Imaging Healthcare | 10.93B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Beijing Wantai Biological Pharmacy Enterprise | 2.49B |